Држава: Ирска
Језик: Енглески
Извор: HPRA (Health Products Regulatory Authority)
Tamsulosin hydrochloride
KRKA, d.d., Novo mesto
G04CA; G04CA02
Tamsulosin hydrochloride
400 microgram(s)
Modified-release capsule, hard
Alpha-adrenoreceptor antagonists; tamsulosin
Marketed
2019-08-13
direction on fibre direction of reading PhC 70 mm ± 0,5 mm 70 mm ± 0,5 mm direction of reading PhC Leaflet folded on middle with visibly first side (title); PhC that comes out of the middle of leaflet must be visible!/ 148 mm ± 0,5 mm 420 mm ± 0,8 mm _ - PMS-433U-KRKA_ _XX PL. TANYZ IE_ first page PACKAGE LEAFLET: INFORMATION FOR THE PATIENT TANYZ 400 micrograms hard modified-release capsules tamsulosin hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What TANYZ is and what it is used for 2. What you need to know before you take TANYZ 3. How to take TANYZ 4. Possible side effects 5. How to store TANYZ 6. Contents of the pack and other information 1. What TANYZ is and what it is used for WHAT IS TANYZ The active ingredient in TANYZ is tamsulosin hydrochloride. This is a selective α 1A/1D -adrenoceptor antagonist. It reduces tension of the smooth muscles in the prostate and the urethra, enabling urine to pass more readily through the urethra and facilitating urination. In addition, it diminishes sensations of urge. TANYZ is used in men for the treatment of the complaints of the lower urinary tract associated with an enlarged prostatic gland (benign prostatic hyperplasia). These complaints may include difficulty urinating (poor stream), dribbling, urgency and having to urinate frequently at night as well as during the day. 2. What you need to know before you take TANYZ DO NOT TAKE TANYZ • if you are ALLERGIC TO TAMSULOSIN OR ANY OF THE OTHER INGREDIENTS OF THIS MEDICINE (list Прочитајте комплетан документ
Health Products Regulatory Authority 01 November 2023 CRN00DT43 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT TANYZ 400 micrograms hard modified-release capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each hard modified-release capsule contains 400 micrograms tamsulosin hydrochloride. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Hard modified-release capsule Orange/olive-green capsule. The capsules contain white to off-white pellets. Capsule dimensions: 19.3 mm x 6.4 mm. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Posology_ One capsule daily, to be taken after breakfast or the first meal of the day. _ _ No dose adjustment is warranted in renal impairment. No dose adjustment is warranted in patients with mild to moderate hepatic insufficiency (see also 4.3 Contraindications). _Paediatric population_ There is no relevant indication for use of tamsulosin in children. The safety and efficacy of tamsulosine in children <18 years have not been established. Currently available data are described in section 5.1 Method of administration For oral use. The capsule should not be broken or pulled apart as this may have an effect on the release of the long-acting active ingredient. 4.3 CONTRAINDICATIONS Hypersensitivity to tamsulosin hydrochloride, including drug-induced angio-oedema, or to any of the excipients listed in section 6.1. A history of orthostatic hypotension. Severe hepatic insufficiency. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE As with other α 1 -adrenoceptors antagonists, a reduction in blood pressure can occur in individual cases during treatment with tamsulosin, as a result of which, rarely, syncope can occur. At the first signs of orthostatic hypotension (dizziness, weakness), the patient should sit or lie down until the symptoms have disappeared. Health Products Regulatory Authority 01 November 2023 CRN00 Прочитајте комплетан документ